Our previous mechanistic characterization of the anti-cancer activity of NSC-743380 in lung cancer cells revealed that NSC-743380 induced robust ROS and suppressed STAT3 activation, both contributed to the anticancer activity of NSC-743380 and its analogues [11, 12, 16]. The gene discussed is STAT3; the disease is lung cancer.